549 related articles for article (PubMed ID: 19444865)
21. Hepatitis C and steatosis.
Björnsson E; Angulo P
Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
[TBL] [Abstract][Full Text] [Related]
22. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients.
Turlin B; Mendler MH; Moirand R; Guyader D; Guillygomarc'h A; Deugnier Y
Am J Clin Pathol; 2001 Aug; 116(2):263-70. PubMed ID: 11488074
[TBL] [Abstract][Full Text] [Related]
23. Iron and proinflammatory cytokines in chronic hepatitis C virus infection.
López-Prieto J; González-Reimers E; Alemán-Valls MR; de la Vega-Prieto MJ; Abreu-González P; Pelazas-González R; Hernández-Luis R; Jorge-Ripper C; Santolaria-Fernández F
Biol Trace Elem Res; 2013 Oct; 155(1):5-10. PubMed ID: 23892696
[TBL] [Abstract][Full Text] [Related]
24. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome.
Piperno A; Vergani A; Salvioni A; Trombini P; Viganò M; Riva A; Zoppo A; Boari G; Mancia G
Liver Int; 2004 Oct; 24(5):471-6. PubMed ID: 15482345
[TBL] [Abstract][Full Text] [Related]
25. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.
Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G
Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109
[TBL] [Abstract][Full Text] [Related]
26. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
Kirsch R; Sijtsema HP; Tlali M; Marais AD; Hall Pde L
Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
[TBL] [Abstract][Full Text] [Related]
27. Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C.
Guyader D; Thirouard AS; Erdtmann L; Rakba N; Jacquelinet S; Danielou H; Perrin M; Jouanolle AM; Brissot P; Deugnier Y
J Hepatol; 2007 Apr; 46(4):587-95. PubMed ID: 17156889
[TBL] [Abstract][Full Text] [Related]
28. Diabetes in chronic liver disease: from old concepts to new evidence.
Picardi A; D'Avola D; Gentilucci UV; Galati G; Fiori E; Spataro S; Afeltra A
Diabetes Metab Res Rev; 2006; 22(4):274-83. PubMed ID: 16506276
[TBL] [Abstract][Full Text] [Related]
29. [Relationship of serum iron and ferritin with the indicators for hepatic fibrosis].
Huang CW; Bai L; Cai JJ; Guo W; Lan L
Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):466-8. PubMed ID: 12754132
[TBL] [Abstract][Full Text] [Related]
30. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
Alexander J; Tung BY; Croghan A; Kowdley KV
Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
[TBL] [Abstract][Full Text] [Related]
31. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
[TBL] [Abstract][Full Text] [Related]
32. Influence of Helicobacter pylori infection on iron accumulation in hepatitis C.
Sumida Y; Kanemasa K; Yamaoka Y; Imamura S; Katoh N; Nakashima T; Tachibana S; Mitsuyoshi H; Itoh Y; Okanoue T
Liver Int; 2006 Sep; 26(7):827-33. PubMed ID: 16911465
[TBL] [Abstract][Full Text] [Related]
33. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease.
Valenti L; Canavesi E; Galmozzi E; Dongiovanni P; Rametta R; Maggioni P; Maggioni M; Fracanzani AL; Fargion S
J Hepatol; 2010 Nov; 53(5):927-33. PubMed ID: 20739079
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.
Nishina S; Hino K; Korenaga M; Vecchi C; Pietrangelo A; Mizukami Y; Furutani T; Sakai A; Okuda M; Hidaka I; Okita K; Sakaida I
Gastroenterology; 2008 Jan; 134(1):226-38. PubMed ID: 18166355
[TBL] [Abstract][Full Text] [Related]
35. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
[TBL] [Abstract][Full Text] [Related]
36. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.
Yamamoto M; Iwasa M; Iwata K; Kaito M; Sugimoto R; Urawa N; Mifuji R; Konishi M; Kobayashi Y; Adachi Y
J Gastroenterol Hepatol; 2007 Apr; 22(4):498-503. PubMed ID: 17376040
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C infection and nonalcoholic fatty liver disease.
Cheung O; Sanyal AJ
Clin Liver Dis; 2008 Aug; 12(3):573-85, viii-ix. PubMed ID: 18625429
[TBL] [Abstract][Full Text] [Related]
38. Iron depletion and response to interferon in chronic hepatitis C.
Carlo C; Daniela P; Giancarlo C
Hepatogastroenterology; 2003; 50(53):1467-71. PubMed ID: 14571765
[TBL] [Abstract][Full Text] [Related]
39. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
[TBL] [Abstract][Full Text] [Related]
40. [Should the insulin resistance associated with hepatic iron overload be researched during diabetes mellitus type II?].
Roblin X; Chevassus P; Boudemaghe T; Palayodan A
Diabetes Metab; 2002 Sep; 28(4 Pt 1):335-9. PubMed ID: 12442073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
